Amodiaquine less effective than chloroquine in the treatment of falciparum malaria in the Philippines. 1987

G Watt, and G W Long, and L Padre, and P Alban, and R Sangalang, and C P Ranoa, and L W Laughlin

Amodiaquine was compared to chloroquine in two groups of Filipino patients with uncomplicated falciparum malaria. Every patient received 25 mg/kg of base orally given over three days. In a hospital study, all eight patients receiving chloroquine cleared their parasitemia by day 6, but six of eight patients receiving amodiaquine failed to clear parasitemia and in four patients there was no response at all (RIII resistance); this difference was significant (P less than 0.01). In a village based study, there was initial clearing of parasitemia in each patient. However, recrudescent infection occurred in all five patients receiving amodiaquine (RI resistance). Five of six falciparum infections were sensitive to chloroquine, while parasitemia reappeared in one patient. In this village, resistance to amodiaquine was significantly more common than resistance to chloroquine (P less than 0.05). To our knowledge, this is the first report of amodiaquine being substantially worse than chloroquine in the treatment of Plasmodium falciparum infection.

UI MeSH Term Description Entries
D008288 Malaria A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia. Marsh Fever,Plasmodium Infections,Remittent Fever,Infections, Plasmodium,Paludism,Fever, Marsh,Fever, Remittent,Infection, Plasmodium,Plasmodium Infection
D008297 Male Males
D010679 Philippines A country in southeastern Asia, archipelago between the Philippine Sea and the South China Sea, and east of Vietnam. The capital is Manila. Philipines,Phillipines,Phillippines
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002738 Chloroquine The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses. Aralen,Arechine,Arequin,Chingamin,Chlorochin,Chloroquine Sulfate,Chloroquine Sulphate,Khingamin,Nivaquine,Sulfate, Chloroquine,Sulphate, Chloroquine
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G Watt, and G W Long, and L Padre, and P Alban, and R Sangalang, and C P Ranoa, and L W Laughlin
April 1984, Lancet (London, England),
G Watt, and G W Long, and L Padre, and P Alban, and R Sangalang, and C P Ranoa, and L W Laughlin
October 1985, Lancet (London, England),
G Watt, and G W Long, and L Padre, and P Alban, and R Sangalang, and C P Ranoa, and L W Laughlin
November 1985, Lancet (London, England),
G Watt, and G W Long, and L Padre, and P Alban, and R Sangalang, and C P Ranoa, and L W Laughlin
September 1995, The Indian journal of medical research,
G Watt, and G W Long, and L Padre, and P Alban, and R Sangalang, and C P Ranoa, and L W Laughlin
November 1983, The American journal of tropical medicine and hygiene,
G Watt, and G W Long, and L Padre, and P Alban, and R Sangalang, and C P Ranoa, and L W Laughlin
March 1994, East African medical journal,
G Watt, and G W Long, and L Padre, and P Alban, and R Sangalang, and C P Ranoa, and L W Laughlin
January 1988, Zhongguo ji sheng chong xue yu ji sheng chong bing za zhi = Chinese journal of parasitology & parasitic diseases,
G Watt, and G W Long, and L Padre, and P Alban, and R Sangalang, and C P Ranoa, and L W Laughlin
February 2008, Memorias do Instituto Oswaldo Cruz,
G Watt, and G W Long, and L Padre, and P Alban, and R Sangalang, and C P Ranoa, and L W Laughlin
September 2001, Annals of tropical medicine and parasitology,
G Watt, and G W Long, and L Padre, and P Alban, and R Sangalang, and C P Ranoa, and L W Laughlin
June 1999, The Journal of infectious diseases,
Copied contents to your clipboard!